TABLE 1. Features of neonatal abstinence syndrome case reporting — six states,* 2018–2021†.
| State (yr)§ | Reporting timeliness,¶ days |
Reporting criteria: clinician diagnosis** | Case follow-up†† | Estimated completeness of case capture,§§ % | Use of case reports |
|
|---|---|---|---|---|---|---|
| To determine NAS incidence, community substance use patterns, and guide program development | To characterize mother-infant hospital discharge disposition | |||||
| Arizona (2017) |
Unknown¶¶ |
Yes |
None |
50–75 |
Yes |
No |
| Florida (2014) |
180 |
Yes |
None |
>75 |
Yes |
No |
| Georgia (2017) |
51 |
Yes: infant toxicology positive.*** transitioning to CSTE case reporting definition.††† |
None |
>75 |
Yes |
No |
| Kentucky (2014) |
66 |
Yes |
None |
>75 |
Yes |
Yes |
| Tennessee (2017) |
28 |
Yes: transitioning to CSTE case reporting definition.††† |
None |
>75 |
Yes |
No |
| Virginia (2017) | 30 | Yes | None | >75 | Yes | No |
Abbreviations: CSTE = Council of State and Territorial Epidemiologists; NAS = neonatal abstinence syndrome.
* Arizona, Florida, Georgia, Kentucky, Tennessee, and Virginia.
† The six states that implemented mandatory NAS reporting during 2013–2017 were invited for voluntary participation in a follow-up questionnaire and telephone interview to review NAS case reporting and surveillance from May 2018 to February 2021.
§ Year legal NAS case reporting mandate became effective; Florida had passive NAS case reporting system from the Agency for Health Care Administration within 6 months of diagnosis.
¶ Average number of days from the time of NAS diagnosis to case report.
** Medical provider diagnosis regardless of whether infant required or was given specific treatment.
†† System or standard operating procedure in place for follow-up of infants with diagnosed NAS or their families once state health department has been notified of the case.
§§ Capture of total case incidence rate via case reporting compared with hospital discharge records.
¶¶ Timeliness is unknown because state-level resources to analyze and monitor completeness received limited NAS case reports.
*** For Georgia, infants with positive toxicology or clinician diagnosis of NAS are reported.
††† https://cdn.ymaws.com/www.cste.org/resource/resmgr/2019ps/final/19-MCH-01_NAS_final_7.31.19.pdf